BRIVESTOBART
UNII 5R52R2P73V

Substance Identification & Data

This profile provides standardized clinical and technical data for Brivestobart, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 5R52R2P73V.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2786639-04-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
5R52R2P73V
CAS Registry Number
2786639-04-9
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
BRIVESTOBART
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C201068
National Cancer Institute reference terminology for clinical and research data.
INN ID
12847
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Brivestobart. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

BRIVESTOBART

Common Names & Synonyms

BRIVESTOBART [INN]
IMMUNOGLOBULIN G4 (229-PROLINE), ANTI-(HUMAN LYMPHOCYTE ACTIVATION GENE-3 PROTEIN) (HUMAN MONOCLONAL GLS-012 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL GLS-012 .KAPPA.-CHAIN, DIMER

Technical Codes

GLS-012

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus